Biotechnology Innovation Organization

What Biotechnology Innovation Organization does

Biotechnology Innovation Organization (BIO) is a 501(c)(6) nonprofit trade association headquartered in Washington, D.C., recognized as the world's largest biotechnology advocacy organization. BIO represents biotech companies, industry leaders, and state biotech associations across more than 35 countries, providing policy advocacy, business development infrastructure, and industry communications. Its membership spans enterprise pharmaceutical companies, early-stage biotech startups, non-R&D firms, state associations, and patient advocacy organizations, with member tiers segmented by Human Health, Startups, and Non-R&D Companies.

BIO's core technology asset is BIO Partnering™, a proprietary digital platform that enables biotech companies, investors, and partners to schedule one-on-one business development meetings during industry events and on a year-round basis. In January 2026, BIO upgraded the platform with an AI Assist feature for generating tailored meeting request messages, deployed first at BIO Partnering @JPM Week 2026, which connected 2,571 registrants from 1,600+ companies across 40+ countries and facilitated 7,577 partnering meetings. BIO's product portfolio centers on a calendar of signature events including the BIO International Convention (San Diego, ~20,000 participants), BIO Asia-Taiwan (Taipei, 2,200+ booths, 10,000+ matchmaking sessions), BIO Europe (Cologne), BIO Partnering for Oncology (Chicago), the BIO Investment & Growth Summit (Miami), and the BIO Patient Advocacy Changemakers Event (Washington, D.C.). Supporting offerings include BIO Business Solutions (a member savings program offering 75% off VWR/Avantor lab supplies), webinars, professional development courses, the BIO Early-Stage Resources Hub, and public-facing microsites on clinical trials and vaccine education.

BIO generates revenue through three primary streams: recurring annual membership dues (quote-based, tiered by sector), event registration fees and corporate sponsorships across the conference portfolio, and the BIO Business Solutions cost-saving program. Its go-to-market combines direct enterprise membership sales, self-service event registration, and a proprietary digital partnering platform. The organization pursues an offensive advocacy posture via amicus briefs (e.g., Ex parte Baurin at the USPTO PTAB in March 2026) and the three-year "Fight of Our Lives" campaign for sustained federal biotech funding. Governance is provided by a member-elected Board of Directors, with John F. Crowley serving as President and CEO.

Name

Biotechnology Innovation Organization

Legal name

Biotechnology Innovation Organization

Website

https://bio.org

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BIO is a 501(c)(6) nonprofit trade association and the world's largest biotechnology advocacy organization, representing biotech companies across 35+ countries through policy advocacy, signature industry events, and the proprietary BIO Partnering™ meeting platform.

Ownership category

akta.pro rank

Product category

Biotechnology Trade Association Services

NAICS

Business Associations (813910), Professional Organizations (81392)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Life Sciences & Biotechnology Congresses (THAHAJAB)

Keywords

• Biotechnology trade association
• Biotech industry advocacy
• Biotech partnering platform
• Biotech conference services
• Membership organization services

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Dues: BIO generates revenue through membership fees from biotech companies, industry leaders, and state biotech associations. Members range from startups to large biopharmaceutical companies united by the goal of developing medical breakthroughs.
2. Event Registration and Sponsorships: Revenue from BIO International Convention, BIO Asia-Taiwan, BIO Europe, BIO Partnering events, and the BIO Investment & Growth Summit through attendee registration fees and corporate sponsorships
3. Member Savings Program: Cost-saving program offering discounts on lab supplies, events, and business solutions to member companies

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

BIO is a membership-based nonprofit trade association that provides biotechnology industry advocacy, business development services through its proprietary BIO Partnering™ meeting platform, and signature conferences including the BIO International Convention, BIO Asia-Taiwan, BIO Europe, and specialty partnering events. Members gain access to policy representation, networking and partnering platforms, member savings programs on lab supplies and business services, and professional development resources.

Product overview

BIO operates as a membership-based biotechnology advocacy organization offering a portfolio of event-based partnering platforms, conferences, and educational resources. The core platform is BIO Partnering™, a digital meeting coordination system used across multiple event properties including the flagship BIO International Convention (world's largest biotech event), regional events (BIO Asia-Taiwan, BIO Europe, BIO Patient Advocacy Changemakers), and specialized partnering services (BIO Partnering @JPM Week, BIO Partnering for Oncology, BIO Investment & Growth Summit). Supporting offerings include BIO Webinars and BIO Professional Development for education, BIO Business Solutions for member discounts, the BIO Early-Stage Resources Hub for startups, and public-facing microsites (Covid Vaccine Facts, Clinical Trials: The Power of Participation). BIO also leads the BioSafe preclinical safety committee initiative and produces content series like Nature's Building Blocks.

Differentiator

Problem solved

Functional benefit

Products and services

• BIO Partnering™ A proprietary digital partnering platform enabling biotech companies, investors, and partners to efficiently schedule one-on-one business development meetings at BIO events and year-round.
• BIO Partnering @JPM Week A partnering service enabling companies to schedule meetings during JPM Healthcare Conference week (January 12-15) at the San Francisco Marriott Marquis and virtually, powered by the BIO Partnering™ system.
• BIO Partnering for Oncology A specialized partnering event focused on oncology dealmaking, held in Chicago during the ASCO Annual Meeting period (May 28-June 2, 2026), enabling connections between cancer therapy innovators, investors, and companies.
• BIO International Convention The world's largest biotech industry event, typically held annually in June with approximately 20,000 participants including global pharma companies, biotech firms, and investment institutions. The 2026 convention took place June 22-25 in San Diego, CA.
• BIO Asia-Taiwan Annual biotechnology conference jointly organized with Taiwan Bio Industry Organization, held at Taipei Nangang Exhibition Center July 15-19, 2026, featuring over 2,200 exhibition booths and more than 10,000 business matchmaking sessions.
• BIO Europe Annual European biotechnology partnering conference held November 9-11, 2026 in Cologne, Germany, facilitating international business development and investment.
• BIO Investment & Growth Summit An annual summit held March 2-3, 2026 in Miami Beach, Florida, bringing together investors and biotech executives for business development, company presentations, and partnering meetings.
• BIO Patient Advocacy Changemakers Event Annual patient advocacy event connecting advocates, industry leaders, and policymakers to advance healthcare innovation and patient access, held October 22-23, 2026 in Washington, D.C.
• BIO Business Solutions Cost-saving program offering BIO members exclusive discounts on lab supplies (including 75% off through VWR/Avantor) and other business services.

Quantifiable outcome

• Over 400,000 partnering meetings requested annually at BIO International Convention
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature2 records

Partnerships

Six partnerships are on record, tiered flagship, minor and core.

• Taiwan Bio Industry OrganizationflagshipStrategic or Co-development Partner · 15 July 2026Joint organizer of BIO Asia-Taiwan 2026 conference, to be held July 15-19 at Taipei Nangang Exhibition Center. The partnership positions Taiwan as an Asia-Pacific hub for biotech innovation and investment.
• Seoul National University Hospital (SNUH)minorStrategic or Co-development Partner · 22 June 2026SNUH operated its first standalone booth at BIO USA 2026 to expand K-Bio global presence and support Korean bio startups in attracting international investment and partnerships.
• Music Beats CancerminorGTM or Marketing Partner · 22 June 2026Nonprofit hosting BreakthroughLive event at BIO 2026 to connect biotech innovators with investors, researchers, and artists in support of cancer therapy development.
• Choate Hall & Stewart LLPminorImplementation/ SI/ Consulting Partner · 5 March 2026Law firm submitted amicus curiae brief on behalf of BIO to USPTO Patent Trial and Appeal Board regarding obviousness-type double patenting doctrine.
• FUJIFILM AmericascoreStrategic or Co-development PartnerCrystal Fry-Vanuch, Head of Government Affairs at FUJIFILM Americas, elected to BIO Board of Directors for 2026-2030 term to guide policy engagement and industry advocacy.
• VWR, Part of AvantorcoreChannel Partner/ Reseller/ DistributorMember savings program offering 75% off lab supplies to BIO member companies through this distribution partnership.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): IFPMA is the global federation of pharma industry associations and companies, representing the broader biopharmaceutical industry on multilateral policy. Its global, multi-stakeholder scope is an adjacent analog to BIO's international advocacy and convention business.
• Informa Connect (BIO Europe operator): Informa operates BIO Europe under license and is a major B2B events and intelligence platform in life sciences. While a partner on BIO Europe, Informa's broader life-sciences events and intelligence business overlaps BIO's conference and partnering portfolio, making it a broad-incumbent peer.

Regional players

• MassBio (Massachusetts Biotechnology Council): MassBio is the largest U.S. state-level biotech trade association, offering membership, advocacy, and networking events in the Massachusetts cluster. While regionally focused, it competes with BIO for dues from biotech members and operates overlapping member-benefit and event services.
• EuropaBio: EuropaBio is the European trade association representing biotechnology companies and industry stakeholders across the EU. It mirrors BIO's continental advocacy and member-service model in Europe and can compete or partner depending on policy scope.
• California Life Sciences (formerly California Life Sciences Association): California Life Sciences is a major state biotech trade association representing one of the largest concentrations of biotech companies in the world. It competes with BIO for California-headquartered member dues and runs regional advocacy and networking that overlap BIO's offerings.
• BioIndustry Association (BIA): BIA is the principal UK biotech trade association, providing advocacy, member services, and partnering events for UK-based biotech companies. Comparable mission and business model to BIO for the UK market, often coordinating with BIO on international advocacy.

Direct peers

• DIA (Drug Information Association): DIA is a global life-sciences association that, like BIO, hosts major industry conferences, runs educational programming, and convenes regulators, industry, and patients. Its annual meeting and neutral-forum positioning in drug development make it a direct functional peer for BIO's event and education portfolio.
• AdvaMed (Advanced Medical Technology Association): AdvaMed is the leading U.S. trade association for medical device and diagnostics manufacturers, mirroring BIO's advocacy, member-services, and policy-engagement model for an adjacent healthcare industry. Comparable in governance structure (501(c)(6)), membership tiers, and Washington-DC policy footprint.
• PhRMA (Pharmaceutical Research and Manufacturers of America): PhRMA is the principal U.S. trade association for the biopharmaceutical industry, paralleling BIO's role on the biotech side. Both organizations advocate for member companies on drug pricing, IP, and regulatory policy, and both run member services; PhRMA's pharma-centric focus is the closest functional analog to BIO's biotech-centric mission.

Others

• ASCO (American Society of Clinical Oncology): ASCO is a professional society for oncology clinicians that runs the ASCO Annual Meeting — a major partnering venue BIO serves with 'BIO Partnering for Oncology' during ASCO week. Adjacent peer on the oncology events and convening function rather than direct association competition.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/IAmBiotech
• LinkedInlinkedin.com/company/biotechnology-innovation-organization
• Xx.com/IAmBiotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotechnology Innovation Organization